Login / Signup

Device profile of the Zephyr endobronchial valve in heterogenous emphysema: overview of its safety and efficacy.

Steven R VergaGerard J Criner
Published in: Expert review of medical devices (2021)
The expert opinion section focuses on outcomes from the LIBERATE Trial and 1-yr post-hoc analysis. Further 5-year follow-up post Zephyr® EBV placement along with protocolization post-EBV placement are needed to minimize adverse events and/or be able to manage, especially with high risk of pneumothorax (PTX).
Keyphrases